Company Overview
| Stock Name | H&H Intl HLDG |
|---|---|
| Stock Code | 01112 |
| Company Full Name | To be extracted |
| Industry | Consumer Discretionary |
| Principal Activities | 本公司在中國提供高端嬰幼兒營養品及護理用品,產品家族包括高端兒童益生菌沖劑、嬰幼兒配方奶粉及乾製嬰幼兒食品,以合生元品牌營銷。 |
| Listing Date | 2010-12-17 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港鰂魚涌太古坊華蘭路18號港島東中心40樓4007至09單位 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | biostime.com.cn |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 11.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | 500 shares |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2010-12-03 to 2010-12-08 |
| Global Offering Shares | 150,000,000 shares |
| HK Public Offer Shares (Initial) | 15,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | 30,000lots (Pool A15,000lots,Pool B15,000lots) |
| International Placing Shares (Initial) | 135,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 600,000,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 6.1% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 1,650,000,000 |
Stock Connect Inclusion Analysis
| Avg Daily HK Mkt Cap | HK$ 10.96B |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣108.3百萬元 |
| Period-End Cash Balance | 人民幣133.8百萬元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2007 | 2008 | 2009 | 2010-06 |
|---|---|---|---|---|
| Revenue | 188,297 | 325,540 | 558,969 | 496,140 |
| Cost of sales | -50,425 | -88,666 | -163,016 | -143,700 |
| Gross profit | 137,872 | 236,874 | 395,953 | 352,440 |
| Other income and gains, net | 554 | 922 | 3,061 | 4,549 |
| Selling and distribution expenses | -95,026 | -168,844 | -248,299 | -190,319 |
| Administrative expenses | -9,992 | -20,321 | -26,462 | -28,361 |
| Profit before tax | 27,402 | 44,606 | 118,153 | 135,795 |
| Income tax expense | -9,916 | -9,444 | -9,836 | -19,042 |
| Profit for the year | 17,486 | 35,162 | 108,317 | 116,753 |
| Profit attributable to owners | 17,487 | 35,066 | 108,317 | 116,753 |
Balance Sheet
| Item | 2007 | 2008 | 2009 | 2010-06 |
|---|---|---|---|---|
| Cash and cash equivalents | 47,935 | 59,765 | 133,795 | 245,329 |
| Trade and bills receivables | 7,862 | 5,588 | 3,653 | 4,584 |
| Inventories | 12,832 | 44,273 | 80,953 | 97,286 |
| Total current assets | 88,265 | 147,429 | 253,664 | 394,814 |
| Total assets | 103,752 | 175,298 | 283,419 | 432,121 |
| Total current liabilities | 63,494 | 86,625 | 112,862 | 180,151 |
| Total liabilities | 63,494 | 86,625 | 112,862 | 180,151 |
| Total equity | 40,258 | 88,673 | 170,557 | 251,970 |
| Equity attributable to owners | 40,235 | 88,422 | 170,557 | 251,970 |
| Interest-bearing borrowings | 0 | 0 | 500 | 0 |
Cash Flow Statement
| Item | 2007 | 2008 | 2009 | 2010-06 |
|---|---|---|---|---|
| Net cash from operating activities | 24,314 | 23,183 | 109,798 | 143,030 |
| Net cash from investing activities | -9,926 | -11,605 | -9,835 | -6,798 |
| Net cash from financing activities | 2,443 | 263 | -25,930 | -24,703 |
| Net increase in cash | 16,831 | 11,841 | 74,033 | 111,529 |
| Depreciation of PP&E | 1,193 | 2,497 | 4,703 | 3,012 |
| Amortisation of intangible assets | 46 | 74 | 92 | 132 |
| Purchase of PP&E | -1,961 | -31,441 | -37,423 | -16,619 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 10.44 |
|---|---|
| First Day Open | HK$ 10.6 |
| First Day Change | -5.09% |
| First Day Volume | 54352000.0 |
| First Day Turnover | 555048000.0 |
| Use of Proceeds | 1、約35%或543.6百萬港元,用于進一步增強及鞏固其品牌認知度及品牌形象;
2、約20%或310.6百萬港元,透過與上游供應商的合作拓展其業務;
3、約15%或233.0百萬港元,用于拓展及發展其銷售分銷網絡及零售渠道;
4、約15%或233.0百萬港元,用于研發投入及擴大生產基礎設施及倉庫;
5、約5%或77.7百萬港元,用于二零一一年起用于升級其信息技術系統;
6、約10%或155.3百萬港元,用于提供資金用作其營運資金及其他一般公司用途。 |
Underwriting Syndicate
Sole Sponsor (1)
香港上海汇丰银行有限公司 CE AAA523
Overall Coordinators (1)
香港上海汇丰银行有限公司 CE AAA523
Joint Bookrunners (1)
香港上海汇丰银行有限公司 CE AAA523
Joint Lead Managers (1)
香港上海汇丰银行有限公司 CE AAA523
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | SD Family Fund L.P. | 99,995,500 HKD | — | 6.10% | — | 6 months | 2011-06-17 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 羅飛 | — |
| Company Secretary | 楊文筠 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 合生元製藥持股75.0%(450,000,000股),由羅飛28.15%、吳熊26.0%、羅雲19.55%、陳富芳11.9%、張文會10.0%及孔慶娟4.4%持有。 |
|---|




